Daxor Corporation

DXR
$10.50 (- $0.03 - 0.28%)
Last updated: 2026-07-08 10:22 UTC
DXR Metrics
Exchange
🇺🇸 NASDAQ XNCM
Nasdaq Capital MarketUnited StatesAmerica/New_York
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINUS2394671034
CUSIP239467103
Market Price10.5
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyYearly
P/E Ratio86.94
EPS0.16
Market Cap$69.3M
Book Value7.15
Price to Book1.946
BetaN/A
52w High14.15
52w Low6.55
Next Earnings DateN/A

Daxor Corporation trades under ticker DXR on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US2394671034, CUSIP 239467103.

About the Company
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.
Price History